Suppr超能文献

[用美多芭治疗血管性帕金森综合征的经验]

[Experience in treating vascular parkinsonism with metamysil].

作者信息

Kamenetskiĭ V K

出版信息

Zh Nevropatol Psikhiatr Im S S Korsakova. 1978;78(3):365-70.

PMID:645311
Abstract

The paper is concerned with a study of the effect of metamizil in 45 patients with different forms of vascular parkinsonism. It was established that metamizil exerts a positive effect on the development of neurological symptoms (rigidity, bradykinesia, tremor) in mild and moderately expressed degrees of lesions. In most of the cases the drugs appeared effective in doses of 0.001 g thrice daily, and in separate cases 0.001 g 6 times daily. In the majority of patients metazil was tolerated without significant side effects. In some patients the side effects (vertigo, dryness in the mouth) were slightly expressed. The effect of treatment was seen after 2 days up to 2 weeks and lasted during the whole course of treatment and sometimes after it. Metamizil possessing a moderate sedative action, as well as spasmolytical and hypotensive is indicated for patients with vascular parkinsonism.

摘要

该论文关注对45例不同类型血管性帕金森病患者使用安乃近的疗效研究。结果表明,安乃近对轻度和中度病变程度的神经症状(僵硬、运动迟缓、震颤)的发展具有积极作用。在大多数情况下,药物每日三次、每次0.001克的剂量有效,个别情况下每日六次、每次0.001克有效。大多数患者对安乃近耐受性良好,无明显副作用。部分患者有轻微的副作用(眩晕、口干)。治疗效果在2天至2周后显现,并在整个治疗过程中持续,有时在治疗后仍持续。安乃近具有适度的镇静作用以及解痉和降压作用,适用于血管性帕金森病患者。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验